FDA Adverse Event Injury Summary report: N

PACIFIC XTREME PTA BALLOON CATHETER

MDR report key: 3181231 · Received June 21, 2013

Report

Report Number
3004066202-2013-00100
Event Type
Injury
Date Received
June 21, 2013
Date of Event
April 10, 2012
Report Date
May 23, 2013
Manufacturer
INVATEC SPA
Product Code
LIT
PMA / PMN Number
K103464
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS: INHERENT RISK OF PROCEDURE ¿ (RESTENOSIS), CONCLUSIONS: INHERENT RISK OF PROCEDURE ¿ (RESTENOSIS). (B)(4).

Description of Event or Problem · 1

PATIENT WAS TREATED WITH AN IMPACT AMPHIPRION PACLITAXEL-ELUTING PTA BALLOON CATHETER IN THE PERONEAL ARTERY DUE TO DETERIORATION OF RUTHERFORD CLASS. HOWEVER A RUPTURE OF THE PERONEAL WAS REPORTED TO HAVE OCCURRED AND 4 STENT GRAFTS WERE IMPLANTED AS TREATMENT. INVESTIGATOR ASSESSED THAT THE RUPTURE OF THE PERONEAL WAS NOT RELATED TO THE STUDY DEVICE. IT WAS REPORTED THAT THE EVENT WAS RESOLVED. LYSIS AND AN AMPHIPRION DEEP PTA BALLOON CATHETER WERE USED TO TREAT OCCLUSION OF THE RIGHT PERONEAL ARTERY ON THE SAME DAY. INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO THE STUDY DEVICE. IT WAS REPORTED THAT THE EVENT WAS RESOLVED. RESTENOSIS OF THE RIGHT PERONEAL OCCURRED APPROXIMATELY 5 MONTHS POST INDEX PROCEDURE AND A PTA PROCEDURE WAS CARRIED OUT. INVESTIGATOR ASSESSED THAT THE EVENT WAS UNLIKELY TO BE RELATED TO THE STUDY DEVICE. OCCLUSION OF THE RIGHT FEM-POP BYPASS AND THE BYPASS ANASTOMOSIS OCCURRED APPROXIMATELY 5 MONTHS POST INDEX PROCEDURE. A PACIFIC XTREME PTA BALLOON CATHETER WAS USED TO TREAT THE SFA. LYSIS AND ROTAREX WERE ALSO CARRIED OUT. INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO THE STUDY DEVICE. IT WAS REPORTED THAT THE EVENT WAS RESOLVED. STENOSIS OF THE RIGHT SFA OCCURRED APPROXIMATELY 5 MONTHS POST INDEX PROCEDURE AND A PTA PROCEDURE WAS CARRIED OUT. AN AMPHIPRION DEEP PTA BALLOON CATHETER AND TWO PACIFIC XTREME PTA BALLOON CATHETERS WERE USED AS TREATMENT. OCCLUSION OF THE FEM-POP BYPASS OCCURRED APPROXIMATELY 10 MONTHS POST INDEX PROCEDURE WHICH WAS TREATED WITH ROTAREX AND PTA PROCEDURE. A PACIFIC XTREME PTA BALLOON CATHETER AND TWO ADMIRAL XTREME PTA BALLOON CATHETERS WERE USED TO TREAT THE RIGHT SFA. INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO THE STUDY DEVICE. IT WAS REPORTED THAT THE EVENT WAS RESOLVED. OCCLUSION OF THE RIGHT PERONEAL OCCURRED APPROXIMATELY 10 MONTHS POST INDEX PROCEDURE AND A PTA WAS CARRIED OUT. A PACIFIC XTREME PTA BALLOON CATHETER WAS USED AS TREATMENT. INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO THE STUDY DEVICE. IT WAS REPORTED THAT THE EVENT WAS RESOLVED. OCCLUSION OF THE RIGHT ATA OCCURRED APPROXIMATELY 10 MONTHS POST INDEX PROCEDURE AND A PTA WAS CARRIED OUT. AN AMPHIPRION DEEP PTA BALLOON CATHETER AND A NON-MEDTRONIC STENT WERE USED AS TREATMENT. INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO THE STUDY DEVICE. IT WAS REPORTED THAT THE EVENT WAS RESOLVED. THROMBUS OF THE TTF OCCURRED APPROXIMATELY 10 MONTHS POST INDEX PROCEDURE AND PTA AND STENTING WAS CARRIED OUT. AN ADMIRAL XTREME PTA BALLOON CATHETER WAS USED TO TREAT THE RIGHT PERONEAL. INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT R ELATED TO THE STUDY DEVICE. IT WAS REPORTED THAT THE EVENT WAS RESOLVED. RESTENOSIS OF THE RIGHT TTF OCCURRED APPROXIMATELY 10 MONTHS POST INDEX PROCEDURE AND A PTA WAS CARRIED OUT. AN IMPACT AMPHIPRION PACLITAXEL-ELUTING PTA BALLOON CATHETER WAS USED TO TREAT THE RIGHT PERONEAL. INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO THE STUDY DEVICE. IT WAS REPORTED THAT THE EVENT WAS RESOLVED. RESTENOSIS OF THE RIGHT ATA OCCURRED APPROXIMATELY 10 MONTHS POST INDEX PROCEDURE AND A PTA WAS CARRIED OUT. AN IMPACT AMPHIPRION PACLITAXEL-ELUTING PTA BALLOON CATHETER WAS USED AS TREATMENT. INVESTIGATOR ASSESSED THAT THE EVENT WAS NOT RELATED TO THE STUDY DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
282253 PACIFIC XTREME PTA BALLOON CATHETER CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL LIT INVATEC SPA

Patients

Seq Age Sex Outcome Treatment
1 00075 YR Hospitalization| R CLOPIDOGREL AND ASPIRIN.